Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif.--(BUSINESS WIRE)--As previously announced on January...
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the...
Company appoints Dr. Samir Mody as Chief Commercial Officer, Dr. Friedrich Asmus as SVP, Clinical Development & Medical Affairs and...
MCLEAN, Va.--(BUSINESS WIRE)--Virtustream, an enterprise-class cloud company and a Dell Technologies business, announced today that OmniSYS, a Dallas-based healthcare technology...
COVID-19 award-winning research presented at Society of Critical Care Medicine Congress CHARLOTTE, N.C.--(BUSINESS WIRE)--#clinicalsurveillance--The 50th Critical Care Congress has wrapped...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable...
LONDON, UK / ACCESSWIRE / February 16, 2021 / World High Life Plc (AQSE:LIFE)(OTCQB:WRHLF), is pleased to announce that Love...
VANCOUVER, BC / ACCESSWIRE / February 16, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), and its exclusive...
OKEMOS, MI / ACCESSWIRE / February 15, 2021 / The Association for Advancing Physician and Provider Recruitment (AAPPR), the leading...
LONDON, UK / ACCESSWIRE / February 15, 2021 / World High Life Plc (AQSE:LIFE)(OTCQB:WRHLF), the investment company with a focus...
Market players are focusing on technology expansion to attain a competitive edge. DUBAI, UAE / ACCESSWIRE / February 15, 2021...
Please read the full announcement in the attached PDF Attachment 2021_07_Stock_Buybackprogram
ATLANTA, Feb. 15, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development...
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in...
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in...
This loan will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in diseases with high...
ADS Offering of $20.1 million in gross proceeds closed on February 12, 2021.Biophytis’s ADSs began trading on the Nasdaq Capital...
Basel, Switzerland, February 15, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into an agreement to...
Press ReleaseNicox’s U.S. Licensee Eyevance Expands U.S. Promotion of ZERVIATE® In Agreement with Hikma February 15, 2021 – release at...
The Neck Hammock is a cervical traction device designed for anyone experiencing mobility problems, neck pain, and tension. It has...